At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 170 enrolled
Drug / intervention
Fluzone High-Dose +1 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study to Assess the Immunogenicity and Reactogenicity of High Versus Standard Dose Trivalent Inactivated Influenza Vaccine for Healthcare Workers
In Brief
A Phase 2 clinical trial evaluating Fluzone High-Dose and Fluzone (standard dose) for Influenza. Completed, enrolled 170 participants across 1 site.
Detailed Summary
The objective of this pilot study is to assess the immunogenicity and reactogenicity of Fluzone High Dose with Fluzone (standard adult dose) influenza vaccines in healthcare workers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfluenza
CountriesCanada
Collaborators--
Timeline
Phase 2CompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartOct 2014
First PostedOct 2014
Primary CompletionJul 2016
Study CompletionDec 2016
TodayJul 2026
First PostedOct 13, 2014
Enrollment StartOct 1, 2014
Primary CompletionJul 1, 2016
Study CompletionDec 31, 2016
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 11.7 years ago
Interventions
Fluzone High-Dosebiological
Influenza vaccine
Fluzone (standard dose)biological
Influenza vaccine